Printer Friendly
The Free Library
19,595,263 articles and books
Member login
User name  
Password 
 
Join us Forgot password?

Aradigm CEO Igor Gonda to Be Interviewed Live on WallSt.Net.


HAYWARD, Calif. -- Aradigm Corporation (OTCBB OTCBB

See OTC Bulletin Board (OTCBB).
:ARDM) (the "Company") today announced that the Company's President and Chief Executive Officer, Igor Gonda, Ph.D. will be featured in a live interview to be broadcast on wallst.net on Friday, November 2, 2007, at 12:00 PM Eastern time.

Dr. Gonda will discuss the Company's pipeline of drug candidates to treat severe respiratory disease, as well as the promising collaborative programs with other healthcare companies that are leveraging Aradigm's technology. He will also describe how a recapitalization in early 2007 positions the Company to pursue its new growth strategy.

To hear the interview in its entirety, visit http://www.wallst.net, and click on "Interviews." The interview can be accessed either by locating the company's ticker symbol Ticker Symbol

An arrangement of characters (usually letters) representing a particular security listed on an exchange or otherwise traded publicly. When a company issues securities to the public marketplace, it selects an available ticker symbol for its securities which investors
 under the appropriate exchange on the left-hand column of the "Interviews" section of the site, or by entering the company's ticker symbol in the Search Archive window once it is posted.

About Aradigm

Aradigm is an emerging specialty pharmaceutical company focused on the development and commercialization of a portfolio of drugs delivered by inhalation for the treatment and prevention of severe respiratory diseases by pulmonologists. Current activities include partnered and self-initiated development programs addressing the treatment of cystic fibrosis cystic fibrosis (sĭs`tĭk fībrō`sĭs), inherited disorder of the exocrine glands (see gland), affecting children and young people; median survival is 25 years in females and 30 years in males. , bronchiectasis bronchiectasis

Abnormal expansion of bronchi in the lungs. It usually results when preexisting lung disease causes bronchial inflammation and obstruction. Bronchial wall fibres degenerate, and bronchi become dilated or paralyzed, preventing removal of secretions, which
, pulmonary hypertension Pulmonary Hypertension Definition

Pulmonary hypertension is a rare lung disorder characterized by increased pressure in the pulmonary artery. The pulmonary artery carries oxygen-poor blood from the lower chamber on the right side of the heart (right
, asthma, inhalation anthrax inhalation anthrax Pulmonary anthrax, woolsorter's disease Pulmonology Occupational anthrax caused by inhalation of Brucella anthracis spores, affecting those exposed to aerosols during early processing of goat or other infected animal hair Clinical  infections and smoking cessation smoking cessation Public health Temporary or permanent halting of habitual cigarette smoking; withdrawal therapies–eg, hypnosis, psychotherapy, group counseling, exposing smokers to Pts with terminal lung CA and nicotine chewing gum are often ineffective. .

In addition, Aradigm's AERx[R] insulin Diabetes Management System (iDMS), which has been licensed to Novo Nordisk for development and commercialization in return for royalties, is in Phase 3 testing for Type 1 and Type 2 diabetes type 2 diabetes
n.
See diabetes mellitus.
. Under the agreements with Novo Nordisk, Novo Nordisk is responsible for all further clinical, manufacturing and commercial development, while Aradigm and Novo Nordisk continue to cooperate and share in technology development, as well as intellectual property development and defense. Novo Nordisk also remains a substantial shareholder and investor in Aradigm. More information about Aradigm can be found at www.aradigm.com.

Aradigm and AERx are registered trademarks and the Aradigm Logo is a trademark of Aradigm Corporation.

About WallSt.net

www.wallst.net is owned and operated by WallStreet Direct, Inc., a wholly owned subsidiary Wholly Owned Subsidiary

A subsidiary whose parent company owns 100% of its common stock.

Notes:
In other words, the parent company owns the company outright and there are no minority owners.
 of Financial Media Group, Inc. (http://www.financialmediagroupinc.com). The Web site is a leading provider of timely business news, executive interviews, multimedia content, and research tools. Financial Media Group, Inc. also owns http://www.mywallst.net, a financial social network for investors, and Financial Filings Corp. (http://www.financialfilings.com), a provider of media and compliance solutions to publicly traded companies. In addition to WallSt.net, WallStreet Direct, Inc. owns and operates WallStRadio (http://www.wallstradio.com), a business and finance podcast Web site. For a complete list of their advertisers, and advertising relationships, visit http://www.wallst.net/disclaimer/disclaimer.asp.

SOURCE: Aradigm
COPYRIGHT 2007 Business Wire
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2007, Gale Group. All rights reserved.

 Reader Opinion

Title:

Comment:



 

Article Details
Printer friendly Cite/link Email Feedback
Publication:Business Wire
Date:Oct 31, 2007
Words:450
Previous Article:Steel Technologies Announces Planned Expansion to New Operations in Juarez, Mexico.
Next Article:Federal Home Loan Bank of San Francisco Releases September 2007 Cost of Funds Index.
Topics:



Related Articles
BRINGING HEALTHY LIVING HOME MORE ARE CUSTOMIZING THEIR SPACE TO MEET VARIED LIFESTYLE NEEDS.
Metal Management reports profits.
WM's Houston HQ goes single-stream.
Substance abuse higher in mid-size cities and rural areas, local policies needed.
Need big spending to school homeless.
Disability savings plan set for parliament.
Films, videos, and dvds.

Terms of use | Copyright © 2012 Farlex, Inc. | Feedback | For webmasters | Submit articles